Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukio Kato

Showing results (1-10 of 420) with videos related to

Pageof 42
Sort By:
Drug Metabolism and Pharmacokinetics|December 27, 2007
Xenobiotic transporter-adaptor networkYukio Kato
Endocrine Journal|February 12, 2024
Development of the anterior pituitary: diverse lineages of the stem/progenitor cellsYukio Kato, Takako Kato
Biological & Pharmaceutical Bulletin|August 4, 2017
Physiological Roles of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Neural CellsNoritaka Nakamichi, Yukio Kato
FEBS Letters|January 3, 2022
Ergothioneine in the brainTakahiro Ishimoto, Yukio Kato
Handbook of Experimental Pharmacology|March 30, 2021
Regulation of Neurogenesis by Organic Cation Transporters: Potential Therapeutic ImplicationsTakahiro Ishimoto, Yukio Kato
Clinical Calcium|October 26, 2016
[Physiolgically-based pharmacokinetics:Theory and examples.]Takahiro Ishimoto, Yukio Kato
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2023
Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney DysfunctionHiroshi Arakawa, Yukio Kato
Journal of Clinical Medicine|April 9, 2016
EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and RegenerationSaishu Yoshida, Takako Kato, Yukio Kato
Cell and Tissue Research|September 22, 2021
New insights into the role and origin of pituitary S100β-positive cellsYukio Kato, Saishu Yoshida, Takako Kato
Pharmaceutical Research|October 31, 2002
Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in ratsMasato Horikawa, Yukio Kato, Yuichi Sugiyama
Pageof 42

Showing results (1-10 of 420) with videos related to

Sort By:
Pageof 42
Drug Metabolism and Pharmacokinetics|December 27, 2007
Xenobiotic transporter-adaptor networkYukio Kato
Endocrine Journal|February 12, 2024
Development of the anterior pituitary: diverse lineages of the stem/progenitor cellsYukio Kato, Takako Kato
Biological & Pharmaceutical Bulletin|August 4, 2017
Physiological Roles of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Neural CellsNoritaka Nakamichi, Yukio Kato
FEBS Letters|January 3, 2022
Ergothioneine in the brainTakahiro Ishimoto, Yukio Kato
Handbook of Experimental Pharmacology|March 30, 2021
Regulation of Neurogenesis by Organic Cation Transporters: Potential Therapeutic ImplicationsTakahiro Ishimoto, Yukio Kato
Clinical Calcium|October 26, 2016
[Physiolgically-based pharmacokinetics:Theory and examples.]Takahiro Ishimoto, Yukio Kato
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2023
Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney DysfunctionHiroshi Arakawa, Yukio Kato
Journal of Clinical Medicine|April 9, 2016
EMT Involved in Migration of Stem/Progenitor Cells for Pituitary Development and RegenerationSaishu Yoshida, Takako Kato, Yukio Kato
Cell and Tissue Research|September 22, 2021
New insights into the role and origin of pituitary S100β-positive cellsYukio Kato, Saishu Yoshida, Takako Kato
Pharmaceutical Research|October 31, 2002
Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in ratsMasato Horikawa, Yukio Kato, Yuichi Sugiyama
Pageof 42